Re-examining the characteristics of pediatric multiple sclerosis in the era of antibody-associated demyelinating syndromes
Göster/ Aç
Erişim
info:eu-repo/semantics/embargoedAccessTarih
01.09.2022Yazar
Yılmaz, ÜnsalGücüyener, Kıvılcım
Yavuz, Merve
Öncel, İbrahim
Canpolat, Mehmet
Saltık, Sema
Ünver, Olcay
Çıtak Kurt, Ayşegül Neşe
Tosun, Ayşe
Yılmaz, Sanem
Özgör, Bilge
Erol, İlknur
Öztoprak, Ülkühan
Aykol Elitez, Duygu
Direk Çobanoğulları, Meltem
Bodur, Muhittin
Teber, Serap
Anlar, Banu
Yıldız, Edibe Pembegül
Yarar, Coşkun
Kara, Bülent
Haspolat, Şenay
İncecik, Faruk
Kutluk, Gültekin
Dilber, Cengiz
Olgaç Dündar, Nihal
Tan, Hüseyin
Öncel, İbrahim
Demir, Ercan
Daşlı Dursun, Büşra
Dilek, Tuğçe Damla
Türkdoğan, Dilşad
Yalnızoğlu, Dilek
Akbaş, Salih
Güleç, Ayten
Yılmaz, Deniz
Ayanoğlu, Müge
Kanmaz, Seda
Güngör, Serdal
Öztürk, Gülten
Beşen, Şeyda
Haliloğlu, Göknur
Balcan Karaca, Nazlı
Öztürk, Selcan
Yüksel, Deniz
Gürkaş, Esra
Oktay, Seçil
Serin, Hepsen Mine
Karadağ, Meral
Akbeyaz, İsmail Hakkı
Yiş, Uluç
Gönüllü Polat, Burçin
Okan, Mehmet Sait
Bektaş, Ömer
Tekin Orgun, Leman
Günbey, Ceren
Per, Hüseyin
Gültutan, Pembe
Büyükkorkmaz Öztürk, Semra
Aksoy, Erhan
Akyüz, Gülcan
Tekgül, Hasan
Kürekçi, Fulya
Hız Kurul, Ayşe Semra
Çarman, Kürşat Bora
Alikılıç, Defne
Duman, Özgür
Kömür, Mustafa
Yıldırım, Miraç
Alıcı, Nurettin
Gümüş, Hakan
Polat, Muzaffer
Konuşkan, Bahadır
Güngör, Olcay
Mert, Gülen Gül
Edizer, Selvinaz
Mıhçı, Filiz
Terzioğlu Öztürk, Sedef
Yavuz, Merve
Tütüncü Toker, Rabia
Arslan, Mutluay
Şahin, Sevim
Gençpınar, Pınar
Yıldırım, Elif
Yüksel, Ersin
Ekici, Arzu
Deniz, Adnan
Yayıcı Köken, Özlem
Okuyaz, Çetin
Yeniay Süt, Nurşah
Atasoy, Ergin
Solmaz, İsmail
Yetkin, Mehmet Fatih
Bilgin, Neslihan
Atasever, Aslı Kübra
Gazeteci Tekin, Hande
Dokurel, İpek
Özçelik, Aysima
Aksoy, Ayşe
Türköz, Ayşe Nur
Çavuşoğlu, Dilek
Özkan, Mehbare
Tekin, Emine
Uygur Şahin, Türkan
Ünalp, Aycan
Koç, Habibe
Sarıgeçili, Esra
Sarıtaş, Serdar
Ayça, Senem
Kayılıoğlu, Hülya
Şenoğlu, Mine Çiğdem
Kamaşak, Tülay
Asadova, Nargis
Keskin, Filiz
Karaoğlu, Pakize
İpek, Rojan
Acer, Hamit
Üst veri
Tüm öğe kaydını gösterKünye
Yılmaz, Ü., Gücüyener, K., Yavuz, M., Öncel, İ., Canpolat, M., Saltık, S., ... & Acer, H. (2022). Re-examining the characteristics of pediatric multiple sclerosis in the era of antibody-associated demyelinating syndromes. European Journal of Paediatric Neurology.Özet
Background: The discovery of anti-myelin oligodendrocyte glycoprotein (MOG)-IgG and anti-aquaporin 4 (AQP4)-IgG and the observation on certain patients previously diagnosed with multiple sclerosis (MS) actually have an antibody-mediated disease mandated re-evaluation of pediatric MS series.
Aim: To describe the characteristics of recent pediatric MS cases by age groups and compare with the cohort established before 2015.
Method: Data of pediatric MS patients diagnosed between 2015 and 2021 were collected from 44 pediatric neurology centers across Türkiye. Clinical and paraclinical features were compared between patients with disease onset before 12 years (earlier onset) and ≥12 years (later onset) as well as between our current (2015-2021) and previous (<2015) cohorts.
Results: A total of 634 children (456 girls) were enrolled, 89 (14%) were of earlier onset. The earlier-onset group had lower female/male ratio, more frequent initial diagnosis of acute disseminated encephalomyelitis (ADEM), more frequent brainstem symptoms, longer interval between the first two attacks, less frequent spinal cord involvement on magnetic resonance imaging (MRI), and lower prevalence of cerebrospinal fluid (CSF)-restricted oligoclonal bands (OCBs). The earlier-onset group was less likely to respond to initial disease-modifying treatments. Compared to our previous cohort, the current series had fewer patients with onset <12 years, initial presentation with ADEM-like features, brainstem or cerebellar symptoms, seizures, and spinal lesions on MRI. The female/male ratio, the frequency of sensorial symptoms, and CSF-restricted OCBs were higher than reported in our previous cohort.
Conclusion: Pediatric MS starting before 12 years was less common than reported previously, likely due to exclusion of patients with antibody-mediated diseases. The results underline the importance of antibody testing and indicate pediatric MS may be a more homogeneous disorder and more similar to adult-onset MS than previously thought.